paper-with-me

Papers

Structural Constraint Integration in Generative Model for Discovery of Quantum Material Candidates

2024-07-05 · Ryotaro Okabe, Mouyang Cheng, Abhijatmedhi Chotrattanapituk, Nguyen Tuan Hung, Xiang Fu, Bowen Han, Yao Wang, Weiwei Xie, Robert J. Cava, Tommi S. Jaakkola, Yongqiang Cheng, Mingda Li

Billions of organic molecules are known, but only a tiny fraction of the functional inorganic materials have been discovered, a particularly relevant problem to the community searching for new quantum materials. Recent advancements in machine-learning-based generative models, particularly diffusion models, show great promise for generating new, stable materials. However, integrating geometric patterns into materials generation remains a challenge. Here, we introduce Structural Constraint Integration in the GENerative model (SCIGEN). Our approach can modify any trained generative diffusion model by strategic masking of the denoised structure with a diffused constrained structure prior to each diffusion step to steer the generation toward constrained outputs. Furthermore, we mathematically prove that SCIGEN effectively performs conditional sampling from the original distribution, which is crucial for generating stable constrained materials. We generate eight million compounds using Archimedean lattices as prototype constraints, with over 10% surviving a multi-staged stability pre-screening. High-throughput density functional theory (DFT) on 26,000 survived compounds shows that over 50% passed structural optimization at the DFT level. Since the properties of quantum materials are closely related to geometric patterns, our results indicate that SCIGEN provides a general framework for generating quantum materials candidates.

📄 PDF Abstract BibTeX arXiv:2407.04557

Code (0)

등록된 구현이 없습니다.

Methods 이 논문이 사용한 방법론

Diffusion Diffusion models generate samples by gradually removing noise from a signal, and their training objective can be expressed as a reweighted variational lower-bound…

Similar Papers 제목 키워드 기반

Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark

2026-06-29 · Matthias Blaschke, Daniel Kienzle, Zsuzsanna Koczor-Benda, Julian Lorenz 외 arxiv

Generative molecular design is shaped by simple proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets. This combination yields strong benchmark metrics but limits transferabilit…

Drug Discovery

Generative Adversarial Networks for Resource State Generation

2026-01-20 · Shahbaz Shaik, Sourav Chatterjee, Sayantan Pramanik, Indranil Chakrabarty arxiv

We introduce a physics-informed Generative Adversarial Network framework that recasts quantum resource-state generation as an inverse-design task. By embedding task-specific utility functions into training, the model lea…

Hybrid quantum cycle generative adversarial network for small molecule generation

2023-12-28 · Matvei Anoshin, Asel Sagingalieva, Christopher Mansell, Dmitry Zhiganov 외

The drug design process currently requires considerable time and resources to develop each new compound that enters the market. This work develops an application of hybrid quantum generative models based on the integrati…

DiversityDrug DesignDrug DiscoveryGenerative Adversarial Network+1

Bridging Quantum and Classical Computing in Drug Design: Architecture Principles for Improved Molecule Generation

2025-06-01 · Andrew Smith, Erhan Guven

Hybrid quantum-classical machine learning offers a path to leverage noisy intermediate-scale quantum (NISQ) devices for drug discovery, but optimal model architectures remain unclear. We systematically optimize the quant…

Bayesian OptimizationDrug DesignDrug Discovery

Hybrid quantum-classical machine learning for generative chemistry and drug design

2021-08-26 · A. I. Gircha, A. S. Boev, K. Avchaciov, P. O. Fedichev 외

Deep generative chemistry models emerge as powerful tools to expedite drug discovery. However, the immense size and complexity of the structural space of all possible drug-like molecules pose significant obstacles, which…

Drug DesignDrug Discovery